Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Warning Letter Scrutinizes Abbott Over Cybersecurity, Battery Lapses

Executive Summary

FDA investigators are concerned Abbott's St. Jude Medical subsidiary failed to adequately address concerns over cybersecurity vulnerabilities and premature battery drain on their cardiac devices manufactured at its Sylmar, Calif., facility.

Advertisement

Related Content

Shuren At FDLI: Least-Burdensome, Real-World Evidence Efforts Picking Up
Feds Holding Workshop on Medical Device Cybersecurity Gaps
FDA Recommends Security Patch For St. Jude Wireless Cardiac Devices
St. Jude Warns Of Battery-Depletion Issues With Some ICDs
St. Jude, Short-Seller Wrestle Over Alleged Security Vulnerabilities

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT104732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel